Vendor, Slingerlands, NY
Pulmokine, Inc.
UEI CJAVXCPZUUM9, CAGE 4XMX0
1 award and $0 obligated between June 27, 2024 and June 27, 2024, 100% under full and open competition, against 31.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Professional, Scientific, and Technical ServicesNAICS 541712 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HHSN268201400013CDefinitive Contract, June 27, 2024, Full and Open Competition, 31 offers | National Institutes of Health NhlbiNational Institutes of Health | Vascular Interventions/Innovations and Therapeutic Advances (Vita): Ind Enabling Studies for a Novel Inhaled PDGF Receptor Inhibitor to TreaNAICS 541712, PSC AN12 | $0 |
- Places of performance
- New York
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 1 across 1 awards